Results 271 to 280 of about 301,544 (297)

COMPLEMENT INHIBITION BY SURFACE BOUND HEPARIN IN CARDIOPULMONARY BYPASS.

Shock, 1997
T E Mollnes, V Videm, P Garred, O Moen, E Øvrum, E. Fosse   +5 more
openaire   +1 more source

Plasma and endothelial cell-surface adhesion molecules and cardiopulmonary bypass

Heart, Lung and Circulation, 2000
Michael P. Vallely, Paul G. Bannon, Clifford F. Hughes, Leonard Kritharides   +3 more
openaire   +1 more source

Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial

Lancet, The, 2019
Robert Caiazzo, Tigran Poghosyan, Fabian Reche   +2 more
exaly  

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

Lancet, The, 2015
Richard P Whitlock, Louis-Mathieu Stevens, Andre Lamy   +2 more
exaly  

Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

Lancet, The, 1999
Afshin Ehsan
exaly  

Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial

Lancet, The, 2013
Matthias Thielmann, Petra Kleinbongard, Daniel Wendt   +2 more
exaly  

Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study

Lancet, The, 2001
Emilia Bagiella
exaly  

Biocompatibility of trillium biopassive surface–coated oxygenator during cardiopulmonary bypass

Journal of Cardiothoracic and Vascular Anesthesia, 2001
openaire   +1 more source

Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial

Lancet, The, 2016
Erik Stenberg, Eva Szabo, Johan Ottosson
exaly  

Depression as a risk factor for mortality after coronary artery bypass surgery

Lancet, The, 2003
James A Blumenthal, Daniel B Mark
exaly